Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Bahn

Showing results (181-190 of 210) with videos related to

Pageof 21
Sort By:
JMIR Formative Research|October 28, 2021
Toward an Extended Definition of Major Depressive Disorder Symptomatology: Digital Assessment and Cross-validation StudyNayra A Martin-Key, Dan-Mircea Mirea, Tony Olmert, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2002
Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22Michael L Mimmack, Margaret Ryan, Hajime Baba, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2009
Transcriptional neoteny in the human brainMehmet Somel, Henriette Franz, Zheng Yan, et al.
Plos One|August 23, 2007
CSF metabolic and proteomic profiles in patients prodromal for psychosisJeffrey T-J Huang, F Markus Leweke, Tsz M Tsang, et al.
Brain and Behavior|May 7, 2021
The Delta Study - Prevalence and characteristics of mood disorders in 924 individuals with low mood: Results of the of the World Health Organization Composite International Diagnostic Interview (CIDI)Nayra A Martin-Key, Tony Olmert, Giles Barton-Owen, et al.
Schizophrenia Research|February 20, 2024
Exploring peripheral biomarkers of response to simvastatin supplementation in schizophreniaJihan K Zaki, Santiago G Lago, Benedetta Spadaro, et al.
JAMA Psychiatry|October 25, 2023
Metabolomic Biomarker Signatures for Bipolar and Unipolar DepressionJakub Tomasik, Scott J Harrison, Nitin Rustogi, et al.
JMIR Research Protocols|August 11, 2020
A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational StudyTony Olmert, Jason D Cooper, Sung Yeon Sarah Han, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 4, 2016
Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confoundersWolfgang Jordan, Henrik Dobrowolny, Sabine Bahn, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 24, 2016
Altered apolipoprotein C expression in association with cognition impairments and hippocampus volume in schizophrenia and bipolar disorderChristian Knöchel, Jonathan Kniep, Jason D Cooper, et al.
Pageof 21

Showing results (181-190 of 210) with videos related to

Sort By:
Pageof 21
JMIR Formative Research|October 28, 2021
Toward an Extended Definition of Major Depressive Disorder Symptomatology: Digital Assessment and Cross-validation StudyNayra A Martin-Key, Dan-Mircea Mirea, Tony Olmert, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2002
Gene expression analysis in schizophrenia: reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22Michael L Mimmack, Margaret Ryan, Hajime Baba, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2009
Transcriptional neoteny in the human brainMehmet Somel, Henriette Franz, Zheng Yan, et al.
Plos One|August 23, 2007
CSF metabolic and proteomic profiles in patients prodromal for psychosisJeffrey T-J Huang, F Markus Leweke, Tsz M Tsang, et al.
Brain and Behavior|May 7, 2021
The Delta Study - Prevalence and characteristics of mood disorders in 924 individuals with low mood: Results of the of the World Health Organization Composite International Diagnostic Interview (CIDI)Nayra A Martin-Key, Tony Olmert, Giles Barton-Owen, et al.
Schizophrenia Research|February 20, 2024
Exploring peripheral biomarkers of response to simvastatin supplementation in schizophreniaJihan K Zaki, Santiago G Lago, Benedetta Spadaro, et al.
JAMA Psychiatry|October 25, 2023
Metabolomic Biomarker Signatures for Bipolar and Unipolar DepressionJakub Tomasik, Scott J Harrison, Nitin Rustogi, et al.
JMIR Research Protocols|August 11, 2020
A Combined Digital and Biomarker Diagnostic Aid for Mood Disorders (the Delta Trial): Protocol for an Observational StudyTony Olmert, Jason D Cooper, Sung Yeon Sarah Han, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 4, 2016
Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confoundersWolfgang Jordan, Henrik Dobrowolny, Sabine Bahn, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 24, 2016
Altered apolipoprotein C expression in association with cognition impairments and hippocampus volume in schizophrenia and bipolar disorderChristian Knöchel, Jonathan Kniep, Jason D Cooper, et al.
Pageof 21